Age and sex distribution of suspected adverse drug reactions to newly marketed drugs in general practice in England: analysis of 48 cohort studies-Reference-Cited by-同舟云学术

Age and sex distribution of suspected adverse drug reactions to newly marketed drugs in general practice in England: analysis of 48 cohort studies

Published:1998-11 Issue:5 Volume:46 Page:505-511
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:British Journal of Clinical Pharmacology

Author:

Martin Richard M.¹,Biswas Pipasha N.¹,Freemantle Shayne N.¹,Pearce Gillian L.¹,Mann Ronald D.¹²

Affiliation:

1. Drug Safety Research Unit, Bursledon Hall, Blundell Lane, Southampton, SO31 1AA

2. School of Medicine, Faculty of Medicine, Health and Biological Sciences, University of Southampton, Southampton

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1046/j.1365-2125.1998.00817.x

Reference18 articles.

1. Towards the safer use of medicines

2. JickHAdverse drug reactions. InTopics in Clinical Pharmacology and Therapeutics ed Maonde RF New York. Springer‐Verlag 1986;397404

3. Safety monitoring: Methodology of the past and of the future

4. OverstallPWAgeing and disease. InText book of Medicine eds Souhami RL Moxham J. Edinburgh London Melbourne and New York. Churchill Livingstone 1990;161181

5. Using the adverse reactions register to study the effects of age and sex on adverse drug reactions

Cited by 151 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Insights from a community-based survey on factors influencing acceptance and uptake of Paxlovid (nirmatrelvir and ritonavir) as a COVID-19 antiviral medication in Singapore;BMC Public Health;2024-08-28

2. PROFILE OF ADVERSE DRUG REACTIONS IN A TERTIARY CARE HOSPITAL: A CROSS-SECTIONAL STUDY;Asian Journal of Pharmaceutical and Clinical Research;2024-06-07

3. Potential of pharmacogenetics in minimizing drug therapy problems in cystic fibrosis;Journal of Cystic Fibrosis;2024-06

4. Competing Benefits and Competing Hazards: The Benefit to Harm Balance in Individual Patients in Rational Therapeutics;Drug Safety;2024-04-30

5. Hypertension Related Co-Morbidities and Complications in Women of Sub-Saharan Africa: A Brief Review;Circulation Research;2024-02-16